2019 Speakers

 

Key Speakers

 

Shinya Yamanaka Director and Professor, Center for iPS Cell Research & Application (CiRA) Kyoto University Center for iPS Cell Research & Application (CiRA) Shinya Yamanaka
Director and Professor, Center for iPS Cell Research & Application (CiRA)
Kyoto University

Kathy High President and Head, Research & Development Spark Therapeutics Spark Therapeutics Kathy High
President and Head, Research & Development
Spark Therapeutics

Dr James Miskin Chief Technical Officer Oxford BioMedica Oxford BioMedica Dr James Miskin
Chief Technical Officer
Oxford BioMedica

Andrew Obenshain Head Of Europe Bluebird Bio Bluebird Bio Andrew Obenshain
Head Of Europe
Bluebird Bio

Dr Andre Choulika Chairman & Chief Executive Officer Cellectis Cellectis Dr Andre Choulika
Chairman & Chief Executive Officer
Cellectis

Pascal Touchon Senior Vice President and Global Head Cell & Gene Novartis Novartis Pascal Touchon
Senior Vice President and Global Head Cell & Gene
Novartis

Alan Smith Executive Vice President, Technical Operations Bellicum Pharmaceuticals Bellicum Pharmaceuticals Alan Smith
Executive Vice President, Technical Operations
Bellicum   Pharmaceuticals

Bob Smith Senior Vice President, Global Gene Therapy Business Pfizer Pfizer Bob Smith
Senior Vice President, Global Gene Therapy Business
Pfizer

Dr Joanne Kurtzberg Director Carolinas Cord Blood Bank At Duke Carolinas Cord Blood Bank At Duke Dr Joanne Kurtzberg
Director
Carolinas Cord Blood Bank At Duke

Dr Roy Baynes SVP & Head Global Clinical Development, Chief Medical Officer Merck Sharp and Dohme (MSD) Merck Sharp and Dohme (MSD) Dr Roy Baynes
SVP & Head Global Clinical Development, Chief Medical Officer
Merck Sharp and Dohme (MSD)

Derek Jantz, Co-founder and CSO, Precision BioSciences Precision BioSciences Derek Jantz
Co-founder and CSO
Precision BioSciences

Fred Chereau, President and CEO, Logic Biotherapeutics Logic Biotherapeutics Fred Chereau
President and CEO
Logic Biotherapeutics

 

 

 

All Speakers

Mayur Abhaya, Managing Director and Chief Executive Officer, Lifecell Ltd

Mayur Abhaya | Managing Director and Chief Executive Officer | Lifecell Ltd » speaking at Advanced Therapies

Mohamed Abou El Enein, Head of Department, Charite Universitatsmedizin

Mohamed Abou El Enein | Head of Department | Charite Universitatsmedizin » speaking at Advanced Therapies

Kathrin Adlkofer, CEO, Cellbox Solutions

Evren Alici, Assistant Professor and Group Leader, Haematology, Karolinska Institutet

Eric Alton, Professor of Gene Therapy and Respiratory Medicine, Faculty of Medicine National Heart and Lung Institute Imperial College London

Jane Andrews, Senior Director of Strategic Marketing, BioBridge Global

Diego Ardigo, R&D Rare Diseases Unit Head, Chiesi Farmaceutici SpA

Stephen Badylak, Deputy Director, McGowan Institute for Regenerative Medicine, University of Pittsburgh

Tomasz Baran, Board Member, PBKM/FamiCord Group

Tomasz Baran | Board Member | PBKM/FamiCord Group » speaking at Advanced Therapies

Vijay Barathan, Life Science Partner, Catapult Ventures

Jacqueline Barry, Chief Clinical Officer, Cell and Gene Therapy Catapult

Shirley Bartido, Director of Regulatory Affairs, Cellectis

Dr Roy Baynes, SVP & Head Global Clinical Development, Chief Medical Officer, Merck Sharp and Dohme (MSD)

Robert Beckman, Managing Partner, The Channel Group, LLC

Robert Beckman | Managing Partner | The Channel Group, LLC » speaking at Advanced Therapies

Tim Bertram, CEO, inRegen

Martin Birchall, Professor of Laryngology, UCL

Jaap Boelens, Chief; Stem Cell Transplantation and Cellular Therapies Pediatrics, Memorial Sloan-Kettering Cancer Center

Cristiana Boi, Researcher, University of Bologna

Greg Bonfiglio, Managing Partner, Proteus Venture Partners

Abhijit Bopardikar, Director, ReeLabs

Abhijit Bopardikar | Director | ReeLabs » speaking at Advanced Therapies

Brian Bronk, Head of Business Development, Rare Diseases & Disorders, Global Business Development & Licensing, Sanofi

Brian Bronk | Head of Business Development, Rare Diseases & Disorders, Global Business Development & Licensing | Sanofi » speaking at Advanced Therapies

John Campbell, Professor and Associate Director, Scottish National Blood Transfusion Service

Susana Cantero Peral, Associate Consultant, Mayo Clinic

Manuel Carrondo, Vice President, iBET: Instituto de Biologia Experimental e Tecnológica

Ben Carter, Chief Technology Officer, CytoSeek

Frederic Chereau, Chief Executive Officer, LogicBio Therapeutics

Frederic Chereau, Chief Executive Officer, LogicBio Therapeutics

Dr Yen Choo, Chief Executive Officer, Progenitor Therapeutics

Dr Andre Choulika, Chairman & Chief Executive Officer, Cellectis

Joana Correia, Executive Director and CSO, Exogenus Therapeutics

David Courtman, Chief Scientific Officer, Northern Therapeutics Inc

Maria Craig, Professor of Paediatric Endocrinology, University of Sydney

Armando Cuesta Díaz, Partner, Ilana Capital

Danielle Curfs, Program Manager Biomedical, Chemelot InSciTe

Cherie Daly, Vice President, Medical Affairs, Celularity

Davide Danovi, Director, HipSci Cell Phenotyping Programme, King's College London

Francesco Dazzi, Professor of Regenerative and Hematological Medicine, King's College London

Dr Robert Deans, CTO, Blue Rock Therapeutics

Dr Robert Deans | CTO | Blue Rock Therapeutics » speaking at Advanced Therapies

Graciana Diez-Roux, Chief Scientific Officer, Telethon Institute of Genetics and Medicine

Simone Dimartino, Lecturer, Institute for Bioengineering, University of Edinburgh

Michael Dombeck, Vice President Of Business Development, Precision Biocciences

Jeff Drew, CSO, Cells4Life Group LLP

Dominik Egger, Research Associate, University of Natural Resources and Life Sciences

Victoria English, Editor, Evernow Publications

Jim Fackler, Associate Professor of Anesthesiology and Critical Care Medicine, John Hopkins School Of Medicine

Jim Fackler | Associate Professor of Anesthesiology and Critical Care Medicine | John Hopkins School Of Medicine » speaking at Advanced Therapies

Prof Farzin Farzaneh, Professor of Molecular Medicine, King's College Hospital NHS Trust

Lucy Foely, Director of biologics, The Centre For Process Innovation (CPI)

Lucy Foely | Director of biologics | The Centre For Process Innovation (CPI) » speaking at Advanced Therapies

Warachaya Fongsarun, Medical Director, THAI StemLife Co.,Ltd.

Miguel Forte, Chief Executive Officer, Zelluna Immunotherapy

Michela Gabaldo, Head of Alliance Management, Fondazione Telethon

Daniel Gibson, Head of Innovation and commercialation, Anthony Nolan

Daniel Gibson | Head of Innovation and commercialation | Anthony Nolan » speaking at Advanced Therapies

Dan Grant, CEO, MTP Connect

Lise Marie Grav, Postdoc, Technical University of Denmark

Adam Gridley, President & CEO, Histogenics Corporation

Uta Griesenbach, Professor Of Molecular Medicine, Imperiai College London

Pascale Guillot, Senior Lecturer of Fetal and Maternal Health, University College London

Pascale Guillot | Senior Lecturer of Fetal and Maternal Health | University College London » speaking at Advanced Therapies

Thomas Hach, Senior Global Health Advisor, Novartis

Joshua Hare, Director of Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine

Hansjörg Hauser, Head of Dept. of Scientific Strategy, Helmholtz Centre for Infection Research GmbH

Frank Hecht, Vice President Marketing and Sales, CellGenix GmbH

Diana Hernandez, Anthony Nolan

Shay Hershcovich, Head of Business Development, Betalin Therapeutics

Kathy High, President and Head, Research & Development, Spark Therapeutics

Edward Hodgkin, Partner, Syncona Partners

Michael Hunt, Chief Executive Officer, ReNeuron Group Plc

Dr Moshe Israeli, Medical Director, Rabin Medical Center

Dr Moshe Israeli | Medical Director | Rabin Medical Center » speaking at Advanced Therapies

Zoran Ivanovic, Scientific Director, French Blood Institute Aquitaine Limousin Branch

Dmitrii Ivolgin, Medical Director, Stem Cells Bank Pokrovski

Audrey Jamieson, Business Development Manager, The Clinical Trial Company Limited

Agnieszka Janeczek, Interim CEO, Renovos

Agnieszka Janeczek | Interim CEO | Renovos » speaking at Advanced Therapies

Derek Jantz, Co-founder and CSO, Precision Biosciences

Dr Bo Kara, Head Process Development, GlaxoSmithKline

Ohad Karnieli, Chief Executive Officer and Co Founder, Atvio Biotechnology

Ohad Karnieli | Chief Executive Officer and Co Founder | Atvio Biotechnology » speaking at Advanced Therapies

Cornelia Kasper, Professor, Biopharmaceutical Production and Technology, B.O.K.U.

Hans Keirstead, Chief Executive Officer,, AiVita Biomedical

Aisha Khan, Executive Director of Laboratory Operations, Interdisciplinary Stem Cell Institute

Aisha Khan | Executive Director of Laboratory Operations | Interdisciplinary Stem Cell Institute » speaking at Advanced Therapies

Sven Kili, Vice President and Head of Gene Therapy Development, Sven Kili Consulting

Sven Kili | Vice President and Head of Gene Therapy Development | Sven Kili Consulting » speaking at Advanced Therapies

Takashi Kei Kishimoto, Chief Science Officer, Selecta Biosciences Inc

Karine Kleinhaus, Divisional Vice President, North America, Pluristem Therapeutics

Wolfgang Knirsch, CEO, Vita34

Wolfgang Knirsch | CEO | Vita34 » speaking at Advanced Therapies

Jim Kovach, Director, Innovation

Nerissa Kreher, Chief Medical Officer, Avrobio

Dr Joanne Kurtzberg, Director, Carolinas Cord Blood Bank At Duke

Dr Joanne Kurtzberg | Director | Carolinas Cord Blood Bank At Duke » speaking at Advanced Therapies

Dmitry Kuzmin, Managing Partner, 4Bio Capital

Jean-Pierre Latere, COO, Celyad

Katarina Le Blanc, Professor/Specialist Physician, Division of Clinical Immunology, Karolinska Institutet

Katarina Le Blanc | Professor/Specialist Physician, Division of Clinical Immunology | Karolinska Institutet » speaking at Advanced Therapies

Jane Lebkowski, President of Research and Development, Regenerative Patch Technologies

Chaim Lebovits, Chief Executive Officer, Brainstorm Cell Therapeutics Inc

Michael Leek, Chief Executive Officer, TC BioPharm

Dave Lennon, President, AveXis Inc

Giovanna Lombardi, Professor of Human Transplant Immunobiology, King's College London

Douglas Losordo, Chief Medical Officer, Caladrius

Douglas Losordo | Chief Medical Officer | Caladrius » speaking at Advanced Therapies

Mark Lowdell, Director of Cellular Therapy, Royal Free London NHS Foundation Trust

Ross Macdonald, Chief Executive Officer, Cynata Therapeutics Ltd

Ross Macdonald | Chief Executive Officer | Cynata Therapeutics Ltd » speaking at Advanced Therapies

Dr Danilo Maddalo, Laboratory Head, Novartis Institutes for Biomedical Research

John Maher, Chief Scientific Officer, Leucid Bio

John Maher | Chief Scientific Officer | Leucid Bio » speaking at Advanced Therapies

Rachel Manley, Head of Global Outreach, Save the Cord Foundation

Rachel Manley | Head of Global Outreach | Save the Cord Foundation » speaking at Advanced Therapies

Marcello Maresca, Associate Director, Astrazeneca Ab

Dr Irene Martini, Lecturer, University La Sapienza

Dr Irene Martini | Lecturer | University La Sapienza » speaking at Advanced Therapies

Irene Mavroudi, Researcher, Public Cord Blood Bank of Crete

Giuseppe Mazza, Chief Executive & Scientific Officer, Engitix

David Mazzo, Chief Executive Officer, Caladrius Biosciences

Ian Mckay, ‎Innovation Lead Advanced Therapies, Innovate UK

Ian Mckay | ‎Innovation Lead Advanced Therapies | Innovate UK » speaking at Advanced Therapies

Nick Medcalf, Innovation Lead - Advanced Therapies, Innovate UK

Nick Medcalf | Innovation Lead - Advanced Therapies | Innovate UK » speaking at Advanced Therapies

Stefano Menegatti, Assistant Professor in Chemical and Biomolecular Engineering, North Carolina State University

Stefano Menegatti | Assistant Professor in Chemical and Biomolecular Engineering | North Carolina State University » speaking at Advanced Therapies

Annamaria Merico, Head of Technology Transfer, Fondazione Telethon

Annamaria Merico | Head of Technology Transfer | Fondazione Telethon » speaking at Advanced Therapies

Joanna Miller, Chief Scientific Officer, Cell Therapy Sciences

Joanna Miller | Chief Scientific Officer | Cell Therapy Sciences » speaking at Advanced Therapies

Brian Miller, Chief Executive Officer, Sentien Biotechnology

Dr James Miskin, Chief Technical Officer, Oxford BioMedica

Claudia Mitchell, Chief Operations Officer, Universal Cells

Fabien Moncaubeig, COO, TreeFrog Therapeutics

Fabien Moncaubeig | COO | TreeFrog Therapeutics » speaking at Advanced Therapies

Neill Moray Mackenzie, Chairman & Board Mamber, Cellular Therapeutics Ltd

Neill Moray Mackenzie | Chairman & Board Mamber | Cellular Therapeutics Ltd » speaking at Advanced Therapies

David Morrow, Project Manager, EATRIS

Artin Moussavi, Chief Business Officer, TC BioPharm

Alan Muir, Director and Co-Founder, Seven Hills Venture Partners

Alan Muir | Director and Co-Founder | Seven Hills Venture Partners » speaking at Advanced Therapies

Sue Mundy, Head of Cord Blood Collection, Anthony Nolan

Mary Murphy, Principle Investigator, Remedi National University of Ireland Galway

Mary Murphy | Principle Investigator | Remedi National University of Ireland Galway » speaking at Advanced Therapies

Gopalan Narayanan, VP, Complex Bio, Voisin Consulting Life Sciences (VCLS)

Josefina Nilsson, Head of Business Unit, Vironova

Andrew Obenshain, Head Of Europe, Bluebird Bio

Jelena Ochs, Manager Business Unit Life Sciences Engineering, Fraunhofer Institute for Production Technology

Dominic O'Reagan, Director & Investor, New Mosaic

Felicia Pagliuca, Co-founder and VP, Cell Biology R&D, Semma Therapeutics

Helen Papadaki, Professor of Haematology, School of Medicine, University of Crete, Head of the Department of Haematology, Public Cord Blood Bank of Crete

Ioannis Papantoniou, ATMP Bioprocessing Coordinator, KU Leuven

Ioannis Papantoniou | ATMP Bioprocessing Coordinator | KU Leuven » speaking at Advanced Therapies

Guy Parkes, Head of Stem Cell Donation, N.H.S. Blood and Transplant

Detlev Parow, Head of Department of Medicines, Therapeutic Appliances and Remedies, D.A.K.

Vivienne Parry, Head of Engagement, Genomics England

Vivienne Parry | Head of Engagement | Genomics England » speaking at Advanced Therapies

David Pauza, Chief Science Officer, American Gene Technologies International Inc.

Amnon Pelz, CEO, Taburit

Amnon Pelz | CEO | Taburit » speaking at Advanced Therapies

Sergey Piletsky, Professor, University of Leicester

Sergey Piletsky | Professor | University of Leicester » speaking at Advanced Therapies

Govind Pindoria, Director of Venture Support Unit, Imperial Innovations

Dr Nicolas Pineault, Development Scientist, Canadian Blood Services

Sarah Haywood Price, Chief Executive Officer, MedCity

Dr Qasim Rafiq, Associate Professor, Bioprocessing of Cell and Gene Therapies, University College London

Dr Qasim Rafiq | Associate Professor, Bioprocessing of Cell and Gene Therapies | University College London » speaking at Advanced Therapies

Kavita Raj, Consultant Haematologist, Guy's And St Thomas' Hospital

Kavita Raj | Consultant Haematologist | Guy's And St Thomas' Hospital » speaking at Advanced Therapies

Ajan Reginald, CEO, Celixir

Katy Rezvani, Chief, Section of Cellular Therapy, MD Anderson Cancer Center

Katy Rezvani | Chief, Section of Cellular Therapy | MD Anderson Cancer Center » speaking at Advanced Therapies

Mike Rice, Principal, Defined Health

Rodney Rietze, Lead CGMP Process Automation, Novartis

Dr Barry Rosen, Senior Principal Scientist/Director, AstraZeneca

Joseph Rotino, Vice President, Quality Assurance and Regulatory Affairs, Cryoport Inc

Mark Sawicki, Chief Commercial Officer, Cryoport Inc

Julia Schaft, Managing Director, BioRN

Katja Schmidt, Head Market Access Oncology,, Novartis

Katja Schmidt | Head Market Access Oncology, | Novartis » speaking at Advanced Therapies

Beth Shaz, Chief Medical Officer, New York Blood Center

Jonathan Sheffield, Chief Executive Officer, NIHR Clinical Research Network

Benjamin Shepherd, Associate Director of R&D, Therapeutics, Organovo

Elizabeth Shpall, Director, MD Anderson Cancer Center

Elizabeth Shpall | Director | MD Anderson Cancer Center » speaking at Advanced Therapies

David Sloman, Chief Executive Officer, Royal Free London NHS Foundation Trust

David Sloman | Chief Executive Officer | Royal Free London NHS Foundation Trust » speaking at Advanced Therapies

Devyn Smith, Chief Operations Officer And Head Of Strategy, Sigilon

Alan Smith, Executive Vice President, Technical Operations, Bellicum Pharmaceuticals

Bob Smith, Senior Vice President, Global Gene Therapy Business, Pfizer

Eric Soller, Vice President of Corporate Development & Strategy, BlueRock Therapeutics

Susan Solomon, Chief Executive Officer and Co-Founder, New York Stem Cell Foundation

Dr Andrea Spezzi, Chief Medical Officer and R&D Head, Orchard Therapeutics

Dr Glyn Stacey, Executive Director, International Stem Cell Banking Initiative

Michael Stein, Chief Executive Officer, Oxstem

Sanja Stifter Md, Phd, Professor, Department of Pathology, Faculty of Medicine, University of Rijeka

Stefanos Theoharis, Senior Vice President of Corporate Development and Partnering, Cell Medica Ltd

Stefanos Theoharis | Senior Vice President of Corporate Development and Partnering | Cell Medica Ltd » speaking at Advanced Therapies

Robert Thomas, EPSRC Career Fellow, EPSRC Centre for Innovative Manufacturing in Regenerative Medicine, Loughborough University

Pascal Touchon, Senior Vice President and Global Head Cell & Gene, Novartis

Dr Frédéric Triebel, Chief Scientific Officer and Medical Officer, Prima Biomed, Ltd

Marc Turner, Medical Director, Scottish National Blood Transfusion Service

Marc Turner | Medical Director | Scottish National Blood Transfusion Service » speaking at Advanced Therapies

Marcos Valadares, Co-Founder, Pluricell

Alain Vertes, Vice President, Alliance Management, Mesoblast Inc

Alain Vertes | Vice President, Alliance Management | Mesoblast Inc » speaking at Advanced Therapies

Rogerio Vivaldi, CEO, Sigilon Therapeutics

Rogerio Vivaldi | CEO | Sigilon Therapeutics » speaking at Advanced Therapies

Dr Ivan Wall, Reader in Department of Biochemical Engineering, Aston University

Dr Michael West, Chief Executive Officer, AgeX Therapeutics

Dr Michael West | Chief Executive Officer | AgeX Therapeutics » speaking at Advanced Therapies

Mathew Wheeler, Associate Director of Europe, VectorBuilder

Michal Wlodarski, Principal, Cambridge Innovation Consulting

David Johannes Wurm, Project Assistant of Biochemical Engineering, Vienne University of Technology

David Johannes Wurm | Project Assistant of Biochemical Engineering | Vienne University of Technology » speaking at Advanced Therapies

Shinya Yamanaka, Director and Professor, Center for iPS Cell Research & Application (CiRA), Kyoto University

Stefano Zancan, Head Clinical Development and Operations, Fondazione Telethon

Xiaokui Zhang, Chief Scientific Officer, Celularity

Dr Mark Zimmerman, Vice President, Business Development and Strategy, ViaCyte

Dr Mark Zimmerman | Vice President, Business Development and Strategy | ViaCyte » speaking at Advanced Therapies
 

 

TO SPONSOR / EXHIBIT

Erica Baeta
+44 (0)207 092 1152
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson
t/ +44 (0)207 092 1150
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor
+44 (0)207 092 1257
issa.mauthoor@terrapinn.com